Lupus Clinical Trials in Los Angeles

Showing 41-60 of 104 trials

Study Using Negative Pressure to Reduce Apnea

NCT04861038

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Sleep Apnea, ObstructiveApnea, Sleep

Sommetrics, Inc.900 participantsStarted Nov 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +12 more locations

COMPLETEDPHASE1< 1 mile

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

NCT03334851

This is a Phase 1 single and multiple dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06835375 in subjects with seropositive SLE or RA. The design is double-blind, sponsor open and placebo controlled. This study will include two parts: Part A and Part B. Part A will consist of single ascending dose cohorts, Part B of multiple ascending dose cohorts. This study will enroll up to a total of approximately 112 subjects at approximately 10 sites.

Systemic Lupus ErythematosusRheumatoid Arthritis

Pfizer74 participantsStarted Nov 2017

Anniston, Alabama, United States • Anniston, Alabama, United States • Beverly Hills, California, United States +14 more locations

Study Using Negative Pressure to Reduce Apnea

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Lupus Trials in Other Cities

Taking Brain Monitoring to the Next Level

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Efficacy of a Sleep Hygiene Toolkit for Patients in ARU

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Abatacept for SLE Arthritis (IM101-330)

Post Approval Study of the remedē System

A Phase II Study of M2951 in SLE

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Comparison of Standing Versus Supine 3D Cone Beam Computed Tomography in Patient With Obstructive Sleep Apnea

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Validating the Use of a Subjectively Reported Sleep Vital Sign

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

Other Conditions in Los Angeles